Summary by Moomoo AI
WuXi Biologics Technologies Co., Ltd. submitted the next trading day disclosure report on September 26, 2024, disclosing changes in its issued shares or treasury shares. In accordance with the requirements of Rule 13.25A of the Listing Rules of The Stock Exchange of Hong Kong Limited and Rule 17.27A of the GEM Listing Rules, the company confirmed that the total number of issued shares remained at 4,154,186,796 shares, with no changes. However, on September 26, 2024, the company bought back 722,000 ordinary shares at a repurchase price ranging from HKD 13.3 to HKD 13.52 per share, with a total consideration of HKD 9,711,510. These shares are intended to be cancelled, and the repurchase activity was carried out based on the repurchase authorization obtained by the company on June 19, 2024. As of now, the total number of shares repurchased by the company under this authorization is 44,420,500 shares, accounting for 1.07% of the shares issued on that day. Following the repurchase, the company will enter into a moratorium period for new share issuance or further sale or transfer of treasury shares until October 26, 2024.
